Ardent Health, Inc. (NYSE:ARDT) Stock Has Average Target Price of $12.79 According to Analysts

Shares of Ardent Health, Inc. (NYSE:ARDT) have been assigned an average recommendation of “Hold” from the fifteen brokerages that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and seven have assigned a buy rating to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $12.79.

A number of equities analysts recently commented on the company. Truist Financial raised their target price on Ardent Health from $12.00 to $13.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Zacks Research raised Ardent Health from a “strong sell” rating to a “hold” rating in a report on Monday, September 7th. BMO Capital Markets assumed coverage on Ardent Health in a research report on Tuesday, September 22nd. They issued a “market perform” rating and a $11.00 price target for the company. Leerink Partners reaffirmed an “outperform” rating and issued a $14.00 price objective on shares of Ardent Health in a research note on Friday, September 18th. Finally, The Goldman Sachs Group reaffirmed a “neutral” rating and set a $13.00 price objective on shares of Ardent Health in a research report on Thursday, August 6th.

Institutional Investors Weigh In On Ardent Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Allworth Financial LP bought a new position in shares of Ardent Health in the second quarter worth approximately $28,000. Caitong International Asset Management Co. Ltd raised its position in shares of Ardent Health by 2,036.6% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 4,786 shares of the company’s stock valued at $42,000 after purchasing an additional 4,562 shares during the period. Integrated Wealth Concepts LLC bought a new stake in shares of Ardent Health during the 2nd quarter valued at $57,000. Monetary Solutions Ltd purchased a new position in shares of Ardent Health during the 4th quarter valued at $79,000. Finally, Abel Hall LLC purchased a new position in shares of Ardent Health during the 1st quarter valued at $87,000.

Ardent Health Stock Down 0.7%

ARDT stock opened at $10.46 on Friday. Ardent Health has a fifty-two week low of $7.71 and a fifty-two week high of $15.48. The business’s 50-day moving average is $10.87 and its two-hundred day moving average is $9.96. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.99 and a current ratio of 2.10. The company has a market cap of $1.48 billion, a price-to-earnings ratio of 19.02, a P/E/G ratio of 2.98 and a beta of 0.71.

Ardent Health (NYSE:ARDT) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.06). The firm had revenue of $1.62 billion for the quarter, compared to the consensus estimate of $1.59 billion. Ardent Health had a net margin of 1.22% and a return on equity of 10.35%. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. As a group, analysts forecast that Ardent Health will post 0.96 earnings per share for the current year.

About Ardent Health

Ardent Health is a U.S. healthcare provider that owns and operates hospitals, outpatient facilities and other healthcare services. The company delivers a broad range of medical care, including emergency services, inpatient and outpatient treatment, primary care, specialty care, surgical services, behavioral health and urgent care.

Headquartered in Nashville, Tennessee, Ardent serves communities through a network of hospitals and healthcare sites in several states, including Texas, Oklahoma, New Mexico and Kansas.